Spondyloarthropathies: IL-17A blockade ameliorates ankylosing spondylitis
- PMID: 26794859
- DOI: 10.1038/nrrheum.2016.7
Spondyloarthropathies: IL-17A blockade ameliorates ankylosing spondylitis
Comment on
-
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Clinical Trial.
References
-
- N Engl J Med. 2015 Dec 24;373(26):2534-48 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials